CA1060862A - Fluid collection device with phase partitioning means - Google Patents

Fluid collection device with phase partitioning means

Info

Publication number
CA1060862A
CA1060862A CA257,284A CA257284A CA1060862A CA 1060862 A CA1060862 A CA 1060862A CA 257284 A CA257284 A CA 257284A CA 1060862 A CA1060862 A CA 1060862A
Authority
CA
Canada
Prior art keywords
tube
blood
collection device
phase
members
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA257,284A
Other languages
French (fr)
Inventor
William D. Cornell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sherwood Medical Co
Original Assignee
Sherwood Medical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sherwood Medical Industries Inc filed Critical Sherwood Medical Industries Inc
Application granted granted Critical
Publication of CA1060862A publication Critical patent/CA1060862A/en
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/491Blood by separating the blood components
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5021Test tubes specially adapted for centrifugation purposes
    • B01L3/50215Test tubes specially adapted for centrifugation purposes using a float to separate phases

Abstract

ABSTRACT OF THE DISCLOSURE
A blood collection device includes a tube for receiving a sample of whole blood for centrifugal separation into the lighter phase, plasma or serum, and the heavier cellular phase. The tube has a needle-pierceable stopper at one end for maintaining a negative pressure in the tube. A
blood phase partitioning device is disposed within the tube and includes an upper cylinder member and a lower piston member slidable in the upper member. The cylindrical member has a plurality of peripheral holes therein and a specific gravity greater than that of the piston member, with the members together having a specific gravity between that of the lighter phase and that of the heavier phase. A sealant is disposed within and in direct contact with the cylindrical member and has a specific gravity substantially equal to that of the two members together. During centrifugation of the blood, the partitioning device automatically moves to the interface of the two phases, and the members move relative to each other forcing the sealant radially outwardly through the peripheral holes in the cylindrical member and against the inner wall of the tube to provide a permanent partition between the two separated phases.

Description

~o~

FLUID COLLECTION DEVICE WITH PHASE PARTITIONING ME~NS
BACKGROUND OF THE INVENTION
This invention relates to fluid collection devices and more particularly to blood collection devices having means for par-titioning the lighter and heavier phases of blood.
In the testing of blood samples, whole blood is usually drawn into an evacuated tube and the tube placed in a centrifuge for separating the lighter and heavier phases so that the indi vidual phases may be isolated and tested. Many different types of phase partitioning devices which provide a barrier or seal between the separated phases have been used or proposed for the purpose of allowing the lighter phase to be decanted or poured into a transfer tube free of cells, or to enable the two phases to remain in the collection tube without intermixing during ship-ment to a laboratory where the lighter phase is removed and sub-jected to analysis.
In U.S. Patent No. 3,852,194 and U.S. Patent No. 3,780,935, gel-like materials, such as a silicone material including a sili-cone fluid and silica powders, is disposed in a collection tube, the gel-like material having a specific gravity between that of the lighter phase and that of the heavier phase so that it flows to the interface of the two phases and forms a partition between them. These devices generally require a relatively large amount of gel-like material, and in addition to the relatively hi~ll cost of the material, a relatively large surface area of the material is in contact with the blood components before, during, and after centrifugation. This relatively large surface area of contact tends to increase the danger of interaction between the gel-like material and lighter blood phase which is to be analyzed. For example, collection tubes are used that employ silicone gel-like materials which produce oil in the lighter phase which tends to - 1 - ~

6V8~;J~
clog and restrict the flow of fluid in the tubing of ~lood ana-lyzing equipment, especially in automatic blood analyzers. This patent also discloses a relatively more complicated arrangement which includes a spool member, such as of rubber, having a hole through it and which has a wiper for sealing contact with the inner wall of the tube. The spooL moves toward the closed end of the tube while the gel-like material moves toward the stopper and closes the hole in the spool member upon separation of the phases.
In U.S. Patent No. 3,909,419, a plasma separator is used wherein a pair of cylinders are disposed in the container and a plurality of micro encapsulated beads of gelà-tin are disposed between the cylinders. The specific gravities of the two cylin-ders and the gelatin beads are such that, by increasing the speed of the centrifuge after the phases have been separated, the cylin-ders move toward each other and rupture the encapsulated beads to cause the gelatin to form a seal between the cylinders and inner wall of the container at a location between the two phases. This arrangement is relatively expensive since it requires the manu-facture of encapsulated beads and also requires centrifugation at two different speeds.
SUM~ARY OF THE INVENTION ~, Accordingly, an object of the present invention is to provide a blood-collection device for receiving a sample of blood adapted to be centrifugally separated into a lighter phase and a heavier cellular phase. The device comprises a closed container tube for receiving the sample of blood, means closing one end of the tube, a needle-pierceable stopper closing the other end of the tube, and a-phase partitioning device within the closed tube including first and second relatively movable members having axially spaced facing surfaces and a combined average specific gravity intermediate tha-t of the liyhter phase and that of the heavier phase and with the
- 2 -6~

first member having a specific gravity greater than that of the second member. A flowable sealant is disposed between the facing surfaces in direct contact with one of the members before centri-fugation, with the sealant having a specific gravity substantially equal to the combined average specific gravity. Both of the mem-bers have a width substantially less than the inner diameter of the tube to allow fluid to readily flow by the partitioning de-vice during separation of the phases, with one of the members having a plurality of circumferentially spacedl radially outwardly extending stabilizing means thereon for maintaining the partition-ing device in a substantially predetermined orientation in the tube during centrifugation of the collection device. The parti-tioning means is movable to a position in the tube adjacent the interface of the phases and the sealant is squeezeable generally radially outwardly from between the facing surfaces and into contact with the inner wall of the tube in response to the rela-tive movement of the spaced surfaces of the members toward each other due to centrifugal forces during centrifugation of the collection device to provide, with the first and second members, a partition sealing the heavier phase from the lighter phase.
These as well as other objects and advantages o~ the present invention will become apparent from the following detailed descrip-tion and drawing.
- 3 o~

BRIEF DESCRIPTION OF THE DRAWING
.
Figure 1 is an elevational cross-sectional view of a blood collection tubecontaining a phase partitioning device in accordance with a preferred embodiment of the present invention, Figure 2 is an elevational cross-sectional view of the col-lection tube of Figure 1 after blood has been drawn into it and during an intermediate stage in the centrifugation of the blood;
and Figure 3 is an elevational cross-sectional view of the col-lection tube shown in Figure 3 but after complete phase separationof the blood.

DESCRIPTION OF THE PREFER~ED EMBODIME~T
.
Referring now to the drawing, and especially to Figure 1, there is shown a fluid collection device 10 including a container or blood collection tube 12 which is preferably of transparent glass and which is shown closed at the bottom by an integral portion 14 of the tube. The tube 12 has an upper open end that is closed by a closure or stopper 16 which extends into the open end in sealing engagement with the side walls of the tube.
The stopper 16 is pierceable by a needle and self-sealing, and may be formed of a suitable elastomer, such as butyl rubber.
The collection tube is provided with a desired negative pressure or partial vacuum that is maintained by the stopper 16. Disposed within the tube 12 ;s a movable blood phase partitioning or separation device 18.

- 3a -s~
A sample of blood may be drawn into the blood collection device , by use of a double-ended needle cannula or a conventional needle holder and tube guide dev~ce (not shown) having a double-ended needle cannula!
For example, after the distal pointed end of the needle cannula is inserted into the vein of a patient, the device 10 is moved within the holder until the proximal pointed end of the needle cannula has pierced the stopper 16 and communicates wittl the interior of the tube l2, whereupon blood flows into the tube. The filled tube is removed from the holder and placed in a centrifuge with the lower end 14 radially outwardly of the stopper and axis of rotation of the centrifuge. The phase partitioning device 18 will ! automatically move within tube 12 during centrifugation, for example, as illustrated in Figures 2 and 3, with the device 18 forming a partition or barrier across the tube in its final position (Figure 3) upon complete separation of the blood into its lighter phase 20, serum or plasma, and its heavier cellular phase 22, as will be more fully discussed hereinafter.
' The phase partitioning device 13 includes an upper, generally cylindrical member ?4, a lower piston member 26, and a gel-like sealant material 28. The upper hollow member includes a cylindrical body portion 30 having interior walls defining a chamber or bore 32 having an open lower end 34 closed by tlle piston member 26 in Figure 1, and an upper end closed by an integral, domed portion 36 having its highest point on the vertical axis of the device 18. The domed portion prevents cells from being trapped on the upper end of the device. The sealant 28 is disposed in bore 32 between the member 26 and the domed portion 36. The member 24 has a plurality of integral stabilizing extensions shown as integral radia11y outwardly extending - stabilizing pins indicated at 38. Four pins 38 are shown adjacent the upper end of member 24 circumferentially spaced 90 apart, and another set of four pins 38 are shown similarly spaced apart adjacent the lower end o~ the member 24. The pins 38 maintain the device 18 in a desired orientation,such as substantially centered along the vertical axis of the tube. The body portion 30 is also pro~ided ~ith a plurality of equally circumferentially spaced openings or holes ~0 extending around the upper portion of the cylindrical body portion 30. These holes extend radially through the side walls of the
-4-; member 24 and are arranged so that the sealant 28 F10ws radially through ~hese holes to provide an even distribution of the sealant around the member 24, as will be described hereinafter.
The two members 24 and 26 are formed so that the average specific gravity of the two members together is intermediate the specific gravity of the separated lighter phase of blood 20, and that of the separated heavier cellular phase 22. Also, the sealant 28 is formed of a material, as will be further discussed, that has a specific gravity which is intermediate the - specific gravities of the two phases and substantially equal to ~he average specific gravity of the two members together. Because the specific gravity of the device 18, that is, of the.two members 24 and 26, and sealant 28 ; together, is intermediate that of separated light and heavy phases, the device 18.wi11 move during centrifugation and arrive at the interface of the two phases upon complete separation of the phases. The specific gravity of the device 18 may be made slightly less than that of whole blood so that the device will tend to start at the top or radially inner end of the blood column. The upper member 24 is made to have a specific gravity greater than that of the lower member 26. The'device 18, when placed in the tube 12, is oriented with the member 26, which has.a lower specific gravity than that of member 24, disposed at the bottom of the tube, as vi.ewed in the drawing, and which is on the radially outer side of the sealant 28 during centrifugation.
With this construction and orientation, the density oF the fluid below or radially outwardly of the device 18 increases during centrlFugation, and - .the two members 24 and 26 move relative to each other because they have di-Fferent specific gravities, the member 26 moving within bore 32 toward the domed portion36 of the member 24. This relative movement of the members 24 and 26 causes the interior surface of the dome portion 36 and the spaced facing upper or interior surface of the member 26 to move toward each other and reduce the space between them to'~thereby cause the sealant 28 to be extruded or squeezed outwardly through holes 40 and into contact with the interior side walls of the tube 12 at the interface of the separated phases 20 and 22, as indicated in Figure 3. The members 24 and 26, and the sealant 28, together, Form a permanent partition or barrler sealing.the separated phases from each other.
-5--;~6~

Since the sealant 24 has a specific g~ayity bet~een that of the lighter phase and that of the heavier phase, i:t seeks its own specific gravity level between the two phases and iorms a seal entirely around the member 24 between the member and the tube.
While various types oE sealant materials may be used, the sealant 28 should be substantially hydrophobic, inert with respect to the blood phases, and,-of course, flowable under pressure condi-tions such as when the member 26 moves upwardly in member 24 as indicated in the drawing. The viscosity or consistency of the sealant 28, the size of holes 40, and the difference between the specific gravities of members 24 and 26, are chosen such that complete phase separation has taken place or all cells have passed the device 18, before the sealant 28 is extruded out into sealing contact with the inner wall of the tube 12. Sealant 28, however, should be substantially non-flowable at rest or after centrifu-gation and subsequent handling, such as tipping of the tube, or during mailing of the tube. Sealant or gel-like materials may be of the types disclosed in the previously mentioned U.S. patents.
For example, gel-like materials of the type disclosed in U~S.
Patent No. 3,852,194 and which include a mixture of silicone fl~id and a powdered inorganlc filler such as hydrophobic silica powder may be used.
Another material which may be used as a sealant is dis-closed in copending Canadian application S.N. 255,754, filed June 25, 1976, and assigned to the assignee of this application.
This material includes a hydrocarbon polymer such as liquid poly-butene, a hydrophobic silica powder, and a hydrophillic silica powder in proportions to provide a sealant having a desired con-sistency and a specific gravity between the specific gravities of the lighter and heavier blood phases. Other materials, for example, other hydrocarbon polymers~ such as liquid butyl rubber and liquid polybutadiene, mixed with suitable fillers, such as hydrophillic and hydrophobic silica, as described in the above application, generally may also be used as a sealant in device 18.
One specific example of a useful sealant which is described in the .. - 6 -above copending application, includes 100 parts by weight of liquid polybutene (Polybutene Grade 24 - Chevron Chemical Co. of San Francisco, California), 20 parts by weight of hydrophillic silica powder (Min-U-Sil-10, PGS, a subsidiary of ITT, Pittsburgh, Pennsylvania), and 9 parts by weight of a hydrophobic silica powder (Aerosil R-972, Degussa Inc., Pigments Division, New York, New York). This sealant did not produce oil in the light phase.
Since the specific gravity of whole blood is generally about 1.05, that of the ~ight phase about 1.03, and that of the heavier phase about 1.08, the average or total specific gravity of the device 18 may be about 1.05 or slightly less as previously mentioned herein. The specific gravity of the two members 24 and 26 together may be about 1.05. The specific gravity of the sealant material 28 may also be about 1.05. The materials used in forming the members 24 and 26 should also be inert with respect to the separated blood phases. Various types of materials are useful in forming these members and each may be formed or molded of one or more plastic materials. The cylindrical member 24 may be formed of a relatively rigid plastic such as poly methylmethacrylate or styrene acrylonitrile. The piston member 26 may be formed of a suitable elastomer or rubber material.
In one case, the liquid polybutene based sealant described in the above specific example was used in a cylindrical member of the above styrene acrylonitrile that had a specific gravity of 1.08. The cylindrical member had about 16 holes (40), each having a diameter of about .025 inch.
The piston member was formed of an elastomer having a specific gravity of about 0.94. This partitioning device provided a good seal between the phases.
The partitioning device 18 may be advantageously inserted during manufacture of the blood collection device so that the stopper 16 does not have to be removed to insert the device into the tube 12. Where the dimensions of device 18 permit a blood clot to pass by it during centrifugation, the blood collection device can be used for both plasma and serum. Where the size of the partitioning device relative to the tube does not permit a blood clot to pass by it, the device 18 may be inserted in tube 12 after the blood has been inserted into the tube and a clot formed or a tube having a removable stopper at each end may be used. In the latter case, blood can, for example, be inserted throuyh one stopper and the collection device centrifuged such ~nat the heavier phase moves toward that stopper and then the lighter.
phase can be remo~ed by removing the stopper at the opposite end of the tube.
l~here the total specific gravity of device lS is less than the average specific gravity of whole blood (but intermediate the specific gravities of the separated phases) it will rise to the top of the wnole blood when the tube is in its upstanding position as shown and the clot or major portion thereof will generally form below i-t. In such case the clot or major portion of the clot will generally not have to pass the partitioning device if the tube is vertically positioned after receiving whole blood and especially where a blood clot activating material is . .
disposed in tne bottom of the tube.
.
The piston member 26 may be sized to sealingly slide within and engage the walls of the cylindrical member 2~ as indicated in the drawing~
; ~lith the piston member closing the bottom of the member 24 and the domed portion 36 closing or substantially closing the top the sealant material is substantially entirely enclosed except for the row of small holes 40 'when the device 18 is in its initial condition (Figure 1) Thus, only a . ' relatively small s.urface area of the sealan.t in'the illustrated 20 ' device is exposed to external fluids. Even during and after centrifugation the surface area of the sealant in contact with the phases is relatively small - since the members 24 and 26 form portions of the partitioning device. Since . the surface area of contact between the sealant and liquids in the tube is relatively small there is less chance Qf undesirable interaction if any between the sealant material used and either phase of blood The size number arrange.ment shape and location of the holes 40 may be varied from that shown in the drawing. For example some holes may be slotted for formed in the-domed portion 36. Also depending upon the design and:shapes of the upper and lower members of device 18 the sealant 30 ' 2~ which is generally tacky such as in the case of the material$ described herein may be in direct contact with both of the members 24 and 26 before centrifugation so that the sealant holds'the members together~ The sealant 28 is a generally homogeneous mixture of materials which mixture is the only material used ~ith the members 24 and 26. In the case of the encapsulated ~ ads disclo~ed in U~S. Patent No~ 3,909~419, the shell or covering material of each bead is in direct contact with the upper and 10wer members, but the sealant or gelatin within the shell material is not in contact with either member before centrifugation, As various changes could be ~ade in the above construction without departing from the scope of the invention, it is intended that all matter contained in the above description or shown in the accompanying drawing shall be interpreted as illustrative and not in a limiting sense, ' .. - .
.

Claims (16)

WHAT IS CLAIMED IS:
1. A blood collection device for receiving a sample of blood adapted to be centrifugally separated into a lighter phase and a heavier cellular phase comprising a closed container tube for receiving the sample of blood, means closing one end of said tube, a needle-pierceable stopper closing the other end of said tube, and a phase partitioning device within said closed tube in-cluding first and second relatively movable members having axially spaced facing surfaces and a combined average specific gravity intermediate that of the lighter phase and that of the heavier phase and with said first member having a specific gravity greater than that of said second member, and a flowable sealant disposed between said facing surfaces in direct contact with one of said members before centrifugation, said sealant having a specific gravity substantially equal to said combined average specific gravity, both of said members having a width substantially less than the inner diameter of said tube to allow fluid to readily flow by said partitioning device during separation of the phases, one of said members having a plurality of circumferentially spaced, radially outwardly extending stabilizing means thereon for maintaining said partitioning device in a substantially pre-determined orientation in said tube during centrifugation of the collection device, said partitioning means being movable to a position in said tube adjacent the interface of the phases and said sealant being squeezeable generally radially outwardly from between said facing surfaces and into contact with the inner wall of said tube in response to the relative movement of said spaced surfaces of said members toward each other due to centrifugal forces during centrifugation of the collection device to provide, with said first and second members, a partition sealing the heavier phase from the lighter phase.
2. The blood collection device of claim 1 wherein said one member is hollow, and the other of said members is movable in said hollow member.
3. The blood collection device of claim 2 wherein said spaced facing surfaces are within said hollow member, and said hollow member has openings through the side wall thereof for the flow of said sealant therethrough.
4. The device of claim 3 wherein said hollow member is said first member.
5. The blood collection device of claim 1 wherein said first member includes a cylindrical portion having one end open and the opposite end substantially closed, said second member being a piston slidable in said cylindrical portion, said cylin-drical portion having a plurality of circumferentially arranged openings in the side wall thereof adjacent to said closed end of said cylindrical portion.
6. The blood collection device of claim 5 wherein said stabilizing means includes first and second sets of radially outwardly extending circumferentially spaced pin members with said sets being axially spaced from each other.
7. The blood collection device of claim 1 wherein said sealant is flowable in response to the movement of said spaced facing surfaces toward each other during centrifugation and is substantially non-flowable after centrifugation.
8. The blood collection device of claim 1 wherein said tube has a negative pressure therein, and said needle-pierceable stopper maintains the negative pressure in said tube.
9. The blood collection device of claim 1 wherein the total specific gravity of said phase partitioning device is less than the average specific gravity of whole blood so that said phase partitioning device will rise to the top of whole blood when said tube is in an upstanding position.
10. The blood collection device of claim 1 wherein said sealant is a generally homogeneous mixture of materials, and said mixture is the only material besides said first and second members used in said partitioning device.
11. The blood collection device of claim 10 wherein said mixture is tacky and in direct contact with both of said first and second members.
12. The blood collection device of claim 1 wherein said means closing one end of said tube is an integral portion of said tube.
13. The blood collection device of claim 12 wherein said tube has a negative pressure therein for drawing whole blood into said tube when said stopper is pierced by a cannula connected with a source of whole blood, and wherein one end of said first member faces said stopper and is between said second member and said stopper.
14. The blood collection device of claim 13 wherein first member has a cylindrical body portion containing said sealant and is closed at said one end thereof and has circumfer-entially spaced openings through the side walls thereof for the flow of said sealant therethrough, and said second member is a piston slidable in said body portion.
15. The blood collection device of claim 1 wherein one end of said first member faces said stopper and is generally domed-shaped so that cells will tend to slide off said first mem-ber.
16. A blood collection device for receiving a sample of blood adapted to be centrifugally separated into a lighter phase and a heavier cellular phase comprising a container tube for receiving the sample of blood and having one end integrally closed, a needle-pierceable stopper sealingly closing the opposite end of said tube, said tube having a negative pressure therein for drawing whole blood into said tube when said stopper is pierced by a cannula connected to a source of whole blood, and a phase partitioning device within said tube including first and second relatively movable members having axially spaced facing surfaces respectively, and a flowable sealant having a specific gravity intermediate those of the lighter and heavier phases disposed be-tween said facing surfaces in direct contact with one of said mem-bers before centrifugation of the collection device, said par-titioning device having a specific gravity which is less than that of whole blood so that it tends to float to the top of the whole blood when whole blood is received in said tube and which is intermediate the specific gravities of the two phases so that during centrifugation said partitioning device moves to a location adjacent to the interface of the two phases, both of said first and second members having a width substantially less than the inner diameter of said tube so that the lighter phase can readily flow past said partitioning device during centrifugation, said first member having stabilizing members extending radially out-wardly from the radial outer walls thereof which are circumfer-entially spaced from each other to maintain said partitioning device substantially centered along the longitudinal axis of said tube, said first member having a specific gravity greater than that of said second member so that said sealant is squeezeable generally radially outwardly from between said facing surfaces and into contact with the inner wall of said tube in response to the relative movement of said spaced surfaces of said members toward each other due to centrifugal forces during centrifugation of the collection device to provide, with said first and second members, a partition sealing the heavier phase from the lighter phase.
CA257,284A 1976-01-16 1976-07-19 Fluid collection device with phase partitioning means Expired CA1060862A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/649,881 US4055501A (en) 1976-01-16 1976-01-16 Fluid collection device with phase partitioning means

Publications (1)

Publication Number Publication Date
CA1060862A true CA1060862A (en) 1979-08-21

Family

ID=24606608

Family Applications (1)

Application Number Title Priority Date Filing Date
CA257,284A Expired CA1060862A (en) 1976-01-16 1976-07-19 Fluid collection device with phase partitioning means

Country Status (9)

Country Link
US (1) US4055501A (en)
JP (1) JPS5935663B2 (en)
AU (1) AU499776B2 (en)
BE (1) BE845177A (en)
BR (1) BR7606696A (en)
CA (1) CA1060862A (en)
DE (1) DE2639389A1 (en)
FR (1) FR2338084A1 (en)
GB (1) GB1552326A (en)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO137663C (en) * 1976-09-30 1978-03-29 Ken Heimreid PROCEDURES FOR EXAMINATION OF UNCOAGULATED BLOOD
US4169060A (en) * 1977-10-25 1979-09-25 Eastman Kodak Company Blood-collecting and serum-dispensing device
US4235725A (en) * 1978-08-16 1980-11-25 Owens-Illinois, Inc. Sterile blood-collecting and separating device
US4569764A (en) * 1979-04-20 1986-02-11 Sherwood Medical Company Collection device with phase partitioning means
US4246123A (en) * 1979-04-20 1981-01-20 Sherwood Medical Industries Inc. Fluid collection device with phase partitioning means
US4369117A (en) * 1980-05-12 1983-01-18 American Hospital Supply Corporation Serum separating method and apparatus
US4315892A (en) * 1980-07-18 1982-02-16 Sherwood Medical Industries, Inc. Fluid collection device having phase partitioning means
SE425993B (en) * 1980-12-23 1982-11-29 Tesi Ab PROCEDURE AND DEVICE FOR TIME-MARKING SEDIMENTATION PROCESSES
US4707276A (en) * 1981-04-15 1987-11-17 Sherwood Medical Company Fluid collection device with phase partitioning means
US4417981A (en) * 1981-05-04 1983-11-29 Becton, Dickinson And Company Blood phase separator device
US4443345A (en) * 1982-06-28 1984-04-17 Wells John R Serum preparator
DE3343887A1 (en) * 1983-12-05 1985-06-13 Walter Sarstedt Kunststoff-Spritzgußwerk, 5223 Nümbrecht ARRANGEMENT FOR PLACING A SEPARATOR BETWEEN TWO PHASES IN A SAMPLE TUBE
SE448323B (en) * 1985-08-27 1987-02-09 Ersson Nils Olof PROCEDURE AND PROCEDURE TO SEPARATE SERUM OR PLASMA FROM BLOOD
GB8621383D0 (en) * 1986-09-04 1986-10-15 Tecumed Wales Ltd Centrifuges
JPH0540447Y2 (en) * 1987-09-14 1993-10-14
US4877520A (en) * 1987-10-08 1989-10-31 Becton, Dickinson And Company Device for separating the components of a liquid sample having higher and lower specific gravities
US4818386A (en) * 1987-10-08 1989-04-04 Becton, Dickinson And Company Device for separating the components of a liquid sample having higher and lower specific gravities
US4946601A (en) * 1988-08-22 1990-08-07 Sherwood Medical Company Blood serum separator tube
CA2011100C (en) * 1989-05-24 1996-06-11 Stephen C. Wardlaw Centrifuged material layer measurements taken in an evacuated tube
US5266199A (en) * 1990-11-20 1993-11-30 Nigata Chemicals And Plastics Co., Ltd. Serum separating apparatus
US5236604A (en) * 1991-05-29 1993-08-17 Sherwood Medical Company Serum separation blood collection tube and the method of using thereof
US5269927A (en) * 1991-05-29 1993-12-14 Sherwood Medical Company Separation device for use in blood collection tubes
US5251474A (en) * 1992-01-16 1993-10-12 Wardlaw Stephen C Centrifuged material layer measurement in an evacuated tube
US5393494A (en) * 1992-05-28 1995-02-28 Diasys Corporation Apparatus for drawing fluid sample, components thereof, and slide assembly for use therewith
US5248480A (en) * 1992-05-28 1993-09-28 Diasys Corporation Apparatus for drawing fluid sample and components thereof
JPH07103969A (en) * 1993-08-13 1995-04-21 Niigata Kako Kk Blood separation member and blood collecting tube for blood separation
US5577513A (en) * 1994-08-31 1996-11-26 Activated Cell Therapy, Inc. Centrifugation syringe, system and method
US5663051A (en) * 1994-08-31 1997-09-02 Activated Cell Therapy, Inc. Separation apparatus and method
US5474687A (en) * 1994-08-31 1995-12-12 Activated Cell Therapy, Inc. Methods for enriching CD34+ human hematopoietic progenitor cells
US5648223A (en) * 1994-08-31 1997-07-15 Activated Cell Therapy, Inc. Methods for enriching breast tumor cells
US5646004A (en) * 1994-08-31 1997-07-08 Activated Cell Therapy, Inc. Methods for enriching fetal cells from maternal body fluids
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US5560830A (en) * 1994-12-13 1996-10-01 Coleman; Charles M. Separator float and tubular body for blood collection and separation and method of use thereof
US5736033A (en) * 1995-12-13 1998-04-07 Coleman; Charles M. Separator float for blood collection tubes with water swellable material
US6406671B1 (en) * 1998-12-05 2002-06-18 Becton, Dickinson And Company Device and method for separating components of a fluid sample
US7947236B2 (en) 1999-12-03 2011-05-24 Becton, Dickinson And Company Device for separating components of a fluid sample
AU7208501A (en) 2000-04-28 2001-11-12 Harvest Technologies Corp Blood components separator disk
US6465256B1 (en) 2000-08-26 2002-10-15 Becton, Dickinson And Company Device and method for separating components of a fluid sample
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US20030205538A1 (en) * 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7179391B2 (en) 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US6905612B2 (en) * 2003-03-21 2005-06-14 Hanuman Llc Plasma concentrate apparatus and method
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US20040182795A1 (en) * 2003-03-21 2004-09-23 Randel Dorian Apparatus and method for concentration of plasma from whole blood
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7074577B2 (en) * 2002-10-03 2006-07-11 Battelle Memorial Institute Buffy coat tube and float system and method
US20040133128A1 (en) * 2003-01-04 2004-07-08 Zhumin Guan Assay device with attachable seal for use with specimen collection and assay containers
US7560272B2 (en) 2003-01-04 2009-07-14 Inverness Medical Switzerland Gmbh Specimen collection and assay container
EP2910258B1 (en) 2005-02-07 2018-08-01 Hanuman LLC Platelet rich plasma concentrate apparatus
EP1848474B1 (en) 2005-02-07 2013-06-12 Hanuman LLC Platelet rich plasma concentrate apparatus and method
WO2006086200A1 (en) * 2005-02-07 2006-08-17 Hanuman Llc Plasma concentrator device
US7866485B2 (en) * 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US7771590B2 (en) * 2005-08-23 2010-08-10 Biomet Manufacturing Corp. Method and apparatus for collecting biological materials
US8048297B2 (en) 2005-08-23 2011-11-01 Biomet Biologics, Llc Method and apparatus for collecting biological materials
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US7806276B2 (en) 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US10106587B2 (en) 2008-02-27 2018-10-23 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
MX366109B (en) * 2008-07-21 2019-06-26 Becton Dickinson Co Density phase separation device.
AU2009274096B2 (en) 2008-07-21 2012-08-02 Becton, Dickinson And Company Density phase separation device
ES2390171T3 (en) 2008-07-21 2012-11-07 Becton, Dickinson And Company Density phase separation device
EP2357471A1 (en) * 2008-11-07 2011-08-17 Hitachi Chemical Company, Ltd. Blood serum or blood plasma separation method
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
SG176028A1 (en) 2009-05-15 2011-12-29 Becton Dickinson Co Density phase separation device
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
KR101069877B1 (en) * 2009-10-28 2011-10-05 임기표 Kit of centrifuge separation and methods for centrifuging using the same
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9937445B2 (en) * 2014-03-27 2018-04-10 Biomet Biologics, Llc System and method for separating a fraction
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device
US9694359B2 (en) 2014-11-13 2017-07-04 Becton, Dickinson And Company Mechanical separator for a biological fluid
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
CN108601565B (en) * 2015-12-11 2021-09-07 巴布森诊断公司 Sample container and method for separating serum or plasma from whole blood
US20220088589A1 (en) 2019-01-21 2022-03-24 Eclipse Medcorp, Llc Methods, Systems and Apparatus for Separating Components of a Biological Sample
WO2022098878A1 (en) * 2020-11-06 2022-05-12 Aftab Alam Method, device, and kit for collecting and processing a biological sample

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780935A (en) * 1972-07-10 1973-12-25 Lukacs & Jacoby Ass Serum separating method
US3852194A (en) * 1972-12-11 1974-12-03 Corning Glass Works Apparatus and method for fluid collection and partitioning
US3909419A (en) * 1974-02-27 1975-09-30 Becton Dickinson Co Plasma separator with squeezed sealant
US3957654A (en) * 1974-02-27 1976-05-18 Becton, Dickinson And Company Plasma separator with barrier to eject sealant
US3920549A (en) * 1974-03-18 1975-11-18 Corning Glass Works Method and apparatus for multiphase fluid collection and separation

Also Published As

Publication number Publication date
FR2338084A1 (en) 1977-08-12
DE2639389A1 (en) 1977-07-21
BE845177A (en) 1976-12-01
GB1552326A (en) 1979-09-12
BR7606696A (en) 1977-11-16
US4055501A (en) 1977-10-25
JPS5288864A (en) 1977-07-25
AU1656376A (en) 1978-02-09
JPS5935663B2 (en) 1984-08-30
AU499776B2 (en) 1979-05-03

Similar Documents

Publication Publication Date Title
CA1060862A (en) Fluid collection device with phase partitioning means
US4088582A (en) Blood phase separation means
US3852194A (en) Apparatus and method for fluid collection and partitioning
US4152270A (en) Phase separation device
US3920549A (en) Method and apparatus for multiphase fluid collection and separation
US4425235A (en) Blood collection device with phase partitioning means
US3931018A (en) Assembly for collection, separation and filtration of blood
US4877520A (en) Device for separating the components of a liquid sample having higher and lower specific gravities
US3887466A (en) Serum/plasma separator cannula fluid by-pass type centrifugal valve cannula seal
JP4722284B2 (en) Apparatus and method for separating components of fluid samples
KR900006418B1 (en) Device for separating the components of a liquid sample having higher and lower specific gravities
US3814248A (en) Method and apparatus for fluid collection and/or partitioning
JP4306902B2 (en) Assembly and method for component separation of fluid samples
US4295974A (en) Blood sample collection and phase separation device
US4046699A (en) Access device for centrifugal separation assemblies
US4417981A (en) Blood phase separator device
US8524171B2 (en) Device for separating components of a fluid sample
CN113751095B (en) Sample container and method for separating serum or plasma from whole blood
US3957654A (en) Plasma separator with barrier to eject sealant
US3897343A (en) Plasma separator-hydrostatic pressure type
US5354483A (en) Double-ended tube for separating phases of blood
US4246123A (en) Fluid collection device with phase partitioning means
US3882021A (en) Sealed assembly for separation of blood with anti-red cell barrier
JP2001235466A (en) Device for separating component of fluid sample
US4707276A (en) Fluid collection device with phase partitioning means